who owns Journavx

Journavx is owned by Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX). The company has developed Journavx and holds the intellectual property rights for the drug. Vertex Pharmaceuticals is a leading biotechnology company that has made significant strides in the development of Journavx, a non-opioid pain relief treatment. The company's ownership of Journavx is a testament to its commitment to innovation and the potential to revolutionize the way acute pain is managed.

JOURNAVX Ownership
|code|stock code|stock name|Last Price|Last Change|Name|market_code|
|---|---|---|---|---|---|---|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Renaissance Technologies, L.L.C.|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Proshare Advisors Llc|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Wallace Capital Management, Inc.|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|The Vanguard Group, Inc.|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|State Street Corporation|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|First Eagle Investment Management, Llc|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Hotchkis And Wiley Capital Management, Llc|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Skylands Capital, Llc|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Russell Investments Group, Ltd.|185|
|JOUT|JOUT.O|Johnson Outdoors|33.54|2.568807|Geode Capital Management, Llc|185|